1. Home
  2. RGC vs STZ Comparison

RGC vs STZ Comparison

Compare RGC & STZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGC
  • STZ
  • Stock Information
  • Founded
  • RGC 2014
  • STZ 1945
  • Country
  • RGC Hong Kong
  • STZ United States
  • Employees
  • RGC N/A
  • STZ N/A
  • Industry
  • RGC Medicinal Chemicals and Botanical Products
  • STZ Beverages (Production/Distribution)
  • Sector
  • RGC Health Care
  • STZ Consumer Staples
  • Exchange
  • RGC Nasdaq
  • STZ Nasdaq
  • Market Cap
  • RGC 38.6B
  • STZ 34.3B
  • IPO Year
  • RGC 2021
  • STZ 1987
  • Fundamental
  • Price
  • RGC $14.66
  • STZ $172.21
  • Analyst Decision
  • RGC
  • STZ Buy
  • Analyst Count
  • RGC 0
  • STZ 18
  • Target Price
  • RGC N/A
  • STZ $212.83
  • AVG Volume (30 Days)
  • RGC 2.8M
  • STZ 2.7M
  • Earning Date
  • RGC 06-30-2025
  • STZ 07-01-2025
  • Dividend Yield
  • RGC N/A
  • STZ 2.37%
  • EPS Growth
  • RGC N/A
  • STZ N/A
  • EPS
  • RGC N/A
  • STZ N/A
  • Revenue
  • RGC N/A
  • STZ $10,061,900,000.00
  • Revenue This Year
  • RGC N/A
  • STZ N/A
  • Revenue Next Year
  • RGC N/A
  • STZ $1.39
  • P/E Ratio
  • RGC N/A
  • STZ N/A
  • Revenue Growth
  • RGC N/A
  • STZ N/A
  • 52 Week Low
  • RGC $0.08
  • STZ $159.35
  • 52 Week High
  • RGC $83.60
  • STZ $264.45
  • Technical
  • Relative Strength Index (RSI)
  • RGC 45.32
  • STZ 53.88
  • Support Level
  • RGC $9.39
  • STZ $168.23
  • Resistance Level
  • RGC $30.00
  • STZ $175.45
  • Average True Range (ATR)
  • RGC 6.44
  • STZ 4.04
  • MACD
  • RGC -1.70
  • STZ 1.57
  • Stochastic Oscillator
  • RGC 20.68
  • STZ 79.30

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

About STZ Constellation Brands Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the U.S., generating 80% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company continue to prune assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the U.S., the firm has small revenue exposure to international markets. Constellation owns a 36% stake in no-moat Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

Share on Social Networks: